Vergelijking

Epitalon vs. Glepaglutide

Twee peptiden naast elkaar — identiteit, bewijsbasis, juridische status en bekende bijwerkingen.

Identiteit

Categorie

Onderzoek (overig)

CAS-nr.

307297-39-8

geen gegevens

Molecuulmassa

390.35 g/mol

geen gegevens

Halfwaardetijd

0.3 h

geen gegevens

Sequentie

Ala-Glu-Asp-Gly

geen gegevens

Werkingsmechanisme

Epitalon

Postulated mechanisms include modulation of gene expression in pinealocytes, telomerase activation (observed in cell culture studies) and influence on melatonin synthesis. A defined primary receptor is not established; the mechanistic basis rests on in-vitro and animal data from the Khavinson group.

Glepaglutide

As a GLP-2 receptor agonist, glepaglutide has a trophic effect on the intestinal mucosa, enlarging the absorptive surface and thereby improving intestinal uptake of nutrients and fluid.

Bewijsbasis

Hoogste bewijs

Humane studie

Humane RCT

Studies

waarvan bij mensen

Geregistreerde effecten

Openstaande tegenstrijdigheden

Gedocumenteerde bijwerkingen

Juridische status

Country	Epitalon	Glepaglutide
Duitsland	Niet goedgekeurd	Niet goedgekeurd
RU	Alleen onderzoek	—
Verenigde Staten	Niet goedgekeurd	Niet goedgekeurd

Volledige vermeldingen

Epitalon

Volledige vermelding →

Glepaglutide

Volledige vermelding →

Frequently asked questions

What is the difference between Epitalon and Glepaglutide?: Epitalon is classified as "Onderzoek (overig)", while Glepaglutide is classified as "Onderzoek (overig)". Epitalon: Synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from the pineal extract epithalamin (V. Khavinson, St. Petersburg). Investigated in the Russian research and anti-ageing context; Western controlled trials are largely absent. No medicines approval in EU or US. Glepaglutide: Glepaglutide is a long-acting GLP-2 analogue (Zealand Pharma) intended to reduce the need for parenteral support in short bowel syndrome. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Epitalon or Glepaglutide?: The highest available evidence level is "Humane studie" for Epitalon and "Humane RCT" for Glepaglutide. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Epitalon and Glepaglutide in Germany and the United States?: Duitsland: Epitalon — Niet goedgekeurd, Glepaglutide — Niet goedgekeurd. Verenigde Staten: Epitalon — Niet goedgekeurd, Glepaglutide — Niet goedgekeurd. These are factual summaries with source and review date on the individual pages.

Country

Epitalon

Glepaglutide

Duitsland

Niet goedgekeurd

Alleen onderzoek

—

Verenigde Staten

Niet goedgekeurd

Frequently asked questions

What is the difference between Epitalon and Glepaglutide?

Epitalon is classified as "Onderzoek (overig)", while Glepaglutide is classified as "Onderzoek (overig)". Epitalon: Synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from the pineal extract epithalamin (V. Khavinson, St. Petersburg). Investigated in the Russian research and anti-ageing context; Western controlled trials are largely absent. No medicines approval in EU or US. Glepaglutide: Glepaglutide is a long-acting GLP-2 analogue (Zealand Pharma) intended to reduce the need for parenteral support in short bowel syndrome. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Epitalon or Glepaglutide?

The highest available evidence level is "Humane studie" for Epitalon and "Humane RCT" for Glepaglutide. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Epitalon and Glepaglutide in Germany and the United States?

Duitsland: Epitalon — Niet goedgekeurd, Glepaglutide — Niet goedgekeurd. Verenigde Staten: Epitalon — Niet goedgekeurd, Glepaglutide — Niet goedgekeurd. These are factual summaries with source and review date on the individual pages.